WallStreetZenWallStreetZen

How to Buy Calidi Biotherapeutics Stock

Calidi Biotherapeutics Inc

Calidi Biotherapeutics is a biotech company located in Virginia, United States, which is part of the Healthcare sector, and is traded under the ticker CLDI on the NYSEMKT exchange.

Calidi Biotherapeutics stock last closed at $0.16, down 17.95% from the previous day, and has decreased 98.44% in one year. It has underperformed other stocks in the Biotechnology industry by 0.72 percentage points. Calidi Biotherapeutics stock is currently +3.23% from its 52-week low of $0.16, and -98.84% from its 52-week high of $13.79.

As of Apr 18, 2024, there are 35.54M CLDI shares outstanding. The market cap of CLDI is $5.69M. In the last 24 hours, 1.45M CLDI shares were traded.

How to Buy Calidi Biotherapeutics Stock

Wondering how to invest in Calidi Biotherapeutics stock? Here's how.
  1. Choose where to buy Calidi Biotherapeutics stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Calidi Biotherapeutics stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Choose your method of payment and add your info.
  4. Analyze Calidi Biotherapeutics stock: The Calidi Biotherapeutics ticker symbol is CLDI. Is Calidi Biotherapeutics stock a good investment? Should you buy shares of CLDI? How do CLDI's underlying business fundamentals look? Do top analysts think Calidi Biotherapeutics is a good buy? Why has CLDI's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if CLDI is a good stock to buy).
  5. Make your CLDI trade: Decide if you will purchase CLDI shares at the current market price or use a limit order to buy CLDI shares at a particular price.
  6. Monitor your CLDI position: Create a watchlist to keep tabs on your investment in Calidi Biotherapeutics shares.

Step 1: Choose where to buy Calidi Biotherapeutics stock

You will need a brokerage account to access the NYSEMKT market and buy CLDI stock.

A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

In our opinion, eToro is the best place to buy stocks. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global markets: From Tech to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've chosen the best brokerage, it's time to fill out some personal info so you are able to invest in CLDI stock today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start a new brokerage account.
  1. Send your info by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you've filled out your info on the best app for stock investing, you need to deposit funds:

Watch the video below for more details depositing money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Calidi Biotherapeutics stock

After you have selected the best place to buy Calidi Biotherapeutics stock, it's crucial to analyze their stock prior to investing, so you truly comprehend the risk as well as the opportunity.

Calidi Biotherapeutics shares data

CLDI Price
$0.16
1w %
-75%
1y %
-98.44%
5y %
N/A
P/E
-0.09x
P/B
-0.69x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$29.22M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$5.69M
Next Earnings
May 29, 2024
Next Dividend
N/A

Calidi Biotherapeutics Fundamentals

WallStreetZen was built to help everyday investors do better fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on CLDI's stock page.

How is CLDI stock valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge CLDI's intrinsic value.

You can access more valuation research on CLDI's stock here.

CLDI Financial Health

Signs that CLDI is not financially healthy:

  • There are more long-term liabilities than short-term assets on the CLDI balance sheet.
  • CLDI has cash burn of 27568000. It does not have sufficient cash and short-term investments to cover this.
  • There are more short-term liabilities than short-term assets on the CLDI balance sheet.
  • Total CLDI debt is still negative.
  • CLDI has $1.95M in cash and short term investments. This is not enough to cover its annual cash burn of $27.57M.
  • CLDI debt to equity ratio of -2.22 is negative.

Is it a good time to buy CLDI stock, according to Wall Street analysts?

Out of 2 sell side analysts who give forecasts on CLDI, the consensus analyst rating on Calidi Biotherapeutics is a Buy

It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are projecting on the Calidi Biotherapeutics stock forecast page.

Metrics for Advanced CLDI Traders

SMA10
0.45
SMA20
0.5
SMA50
0.61
SMA100
1.07
SMA200
3.64
MACD
-0.09
MACD Signal
-0.06
MACD Histogram
-0.03
RSI
30.84
Stochastic %K
1.14
Stochastic %D
19.53
StochRSI %K
6.82
StochRSI %D
32.78

CLDI Performance Numbers

Last year, CLDI revenue was $0.00. During the last 2 year, CLDI's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 28.98%.

You can research CLDI's earnings and revenue performance here.

Latest Insiders Trades at CLDI

Over the last year, executives and large shareholders at CLDI have sold more shares than they have bought.

Scott Leftwich, Director of CLDI, was the latest CLDI insider to buy. They bought $16,124.40 worth of CLDI shares on Dec 21, 2023.

Get more info about who owns CLDI shares here.

Can I rely on CLDI as an income stream?

No, Calidi Biotherapeutics doesn't provide an income stream by paying out dividends.

What others are saying about CLDI

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your CLDI trade

You have two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a specific price limit, use a limit order.

Click the Open Trade button and eToro will place the order.

If you require more assistance buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Monitor your CLDI position

Now that you own some CLDI shares, you'll want to stay up-to-date on your new company.

Create a watchlist to track your CLDI stock.

CLDI Feed

No news
There is no news on the companies in your watchlist or you don't have enough companies added to your list.

How to Buy Stock in Calidi Biotherapeutics

To reiterate, here are the 6 steps you need to take to buy Calidi Biotherapeutics stock right now:

  1. Choose where to buy Calidi Biotherapeutics stock
  2. Create a brokerage account
  3. Fund your investment account
  4. Analyze Calidi Biotherapeutics stock
  5. Make your CLDI trade
  6. Monitor your CLDI position

If you are looking for a brokerage account, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to watch your new investment in Calidi Biotherapeutics, add CLDI to your watchlist by clicking the button below.

NYSEMKT: CLDI
$0.16-0.04 (-17.95%)
Updated Apr 18, 2024
Open eToro Account
NYSEMKT: CLDI
$0.16-0.04 (-17.95%)
Updated Apr 18, 2024
Open eToro Account

FAQ

How much does it cost to buy one Calidi Biotherapeutics share?

As of Apr 18, 2024, it costs $0.16 to buy one share of Calidi Biotherapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.08, you can buy 0.5 shares of CLDI.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Calidi Biotherapeutics stock?

According to 2 Wall Street analysts who monitor Calidi Biotherapeutics, their consensus recommendation is to buy Calidi Biotherapeutics stock.

What is the best way to buy Calidi Biotherapeutics stock?

One way to place an order for Calidi Biotherapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.